AbbVie Inc $55.28

down -0.32


29/8/2014 04:00 PM  |  NYSE : ABBV  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get ABBV Trend Analysis - it has outperformed the S&P 500 by 7%

Partner Headlines

  1. I Am Sure This Pharma-Company Suits Your Portfolio

    GuruFocus
  2. Benzinga's M&A Chatter for Wednesday August 27, 2014

    Benzinga
  3. After Reaching All-Time Highs, How Can Gilead Sciences Continue growing?

    GuruFocus
  4. Bristol-Myers Hepatitis C Therapy Approved in EU

    IBD
  5. IRS, Eh? Tim Hortons Deal Could Lower Burger King's Tax Bill

    FoxBusiness
  6. Why Burger King Isn't Like Walgreen In Tax Inversions

    IBD
  7. Biotech Leader Gilead Sciences Scores Sovaldi Win

    IBD
  8. Gilead Wins Sovaldi Dispute With Roche, U.K. Nod

    IBD
  9. 5 Companies That Have Moved Overseas For Lower Taxes

    Benzinga
  10. GW Pharma, Insys Face Off In Cannabis Drug Space

    IBD
  11. Markets Little Changed As Ukraine Uncertainty And Fears Persist

    Benzinga
  12. Walgreen Leads Sell-Off In 'Tax Inversion' Stocks

    IBD
  13. #PreMarket Primer: Wednesday, August 6: Sprint Prepares To Go It Alone

    Benzinga
  14. Walgreen Seen Rejecting Tax Inversion Amid Pressure

    IBD
  15. Walgreen Names New CFO Ahead of Possible Inversion

    IBD
  16. Amgen Cancer Drug Kyprolis Succeeds In Trial

    IBD
  17. Salix, Actavis Lead IBD 50 Drug Earnings This Week

    IBD
  18. US M&A Announced Deals Surpass $1 Trillion For 2014

    Benzinga
  19. Pharmacyclics Q2 Earnings Get Mixed Reception

    IBD
  20. The Stocks Already in Correction Mode

    FoxBusiness
  21. Markets Little Changed Ahead Of The Federal Reserve's Policy Decision

    Benzinga
  22. How Obama Could End Walgreen's Tax-Inversion Hopes

    IBD
  23. UPDATE: UBS Upgrades AbbVie

    Benzinga
  24. AbbVie Beats Earnings Views, Sees Slower Humira Gain

    IBD
  25. #PreMarket Primer: Thursday, July 24: Facebook Proves Its Worth

    Benzinga
  26. FT: 25 More Firms May Seek Tax Breaks Overseas

    FoxBusiness
  27. Benzinga's Weekend M&A Chatter

    Benzinga
  28. AbbVie Clinches Shire Deal

    IBD
  29. Investors Focus On Earnings Rather Than Geopolitical Tensions

    Benzinga
  30. Will Congress Scuttle the AbbVie-Shire Merger?

    FoxBusiness
  31. AbbVie Buys Shire For $54 Billion

    IBD
  32. Stocks Futures Up On Q2 Reports; Abbvie-Shire, Google Positive

    IBD
  33. Benzinga's Top #PreMarket Losers

    Benzinga
  34. AbbVie to Acquire Shire for £24.44 in Cash and 0.8960 New AbbVie Shares

    Benzinga
  35. Markets Sell-Off After Malaysian Airline Crash In Ukraine

    Benzinga
  36. Treasury Urges Halt to Tax Inversion M&A 'Abuse'

    IBD
  37. J&J Earnings Beat Estimates, But Guidance Mixed

    IBD
  38. Bank Of America Boosts AbbVie PT On Increased Likelihood Of Deal

    Benzinga
  39. Irish Stocks Come To Prominence As Taxes Stay Low

    IBD
  40. AbbVie Near $54 Bil Shire Buy

    IBD
  41. Mylan, AbbVie News Shows Tax Inversion Boom Continues

    IBD
  42. Dow Sets New Intraday High; Citigroup Impresses With Earnings

    Benzinga
  43. Stocks On Pace For Second Gain; Kandi Keeps Soaring

    IBD
  44. Mylan Buying Abbott Generics Unit, Moving Abroad

    IBD
  45. Can Investors Profit From Friday's Rumors? Depends Who You Ask

    Benzinga
  46. Benzinga's Top #PreMarket Losers

    Benzinga
  47. US Stock Futures Surge; All Eyes On Citigroup Results

    Benzinga
  48. Benzinga's Weekend M&A Chatter

    Benzinga
  49. Walgreen Tax Inversion: Masking A Weak Business?

    YCharts
  50. Markets Close Higher Ahead Of Busy Earnings Season

    Benzinga
Trading Center